Outpatient Parenteral Antimicrobial Therapy Plus Buprenorphine for Opioid Use Disorder and Severe Injection-related Infections | Zendy

Laura Fanucchi | Zendy; Sharon Walsh | Zendy; Alice Thornton | Zendy; Paul A. Nuzzo | Zendy; Michelle R. Lofwall | Zendy

Open Access

Outpatient Parenteral Antimicrobial Therapy Plus Buprenorphine for Opioid Use Disorder and Severe Injection-related Infections

Author(s) -

Laura Fanucchi,

Sharon Walsh,

Alice Thornton,

Paul A. Nuzzo,

Michelle R. Lofwall

Publication year - 2019

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/ciz654

Subject(s) - medicine , buprenorphine , antimicrobial , opioid use disorder , clinical trial , randomized controlled trial , opioid , antibiotics , intensive care medicine , emergency medicine , surgery , chemistry , receptor , organic chemistry , microbiology and biotechnology , biology

In a pilot randomized trial in persons with opioid use disorder hospitalized with injection-related infections, an innovative care model combining outpatient parenteral antimicrobial therapy with buprenorphine treatment had similar clinical and drug use outcomes to usual care (inpatient intravenous antibiotic completion) and shortened hospital length of stay by 23.5 days.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research